| Issue |
Section |
Title |
File |
| Vol 50, No 3 (2016) |
Drugs |
Analysis of Factors Influencing the Interchangeability of Antiepileptic Drugs |
|
| Vol 50, No 5 (2016) |
Article |
Development of Pharmacopoeial Methods for Determining the Anticomplementary Activity of Human Immunoglobulin Preparations |
|
| Vol 50, No 9 (2016) |
Article |
Selection of Standardization Parameters and Development of Quality Control Methods for Isoleucyl-Tryptophan Dipeptide Coordination Complex with Iron(II) (Timofer) |
|
| Vol 50, No 9 (2016) |
Article |
Method Validation for Anticomplementary Activity of Human Immunoglobulin Drugs |
|
| Vol 50, No 10 (2017) |
Drugs |
Interchangeability Criteria for Levofloxacin-Based Medicinal Products in the Russian Federation |
|
| Vol 50, No 12 (2017) |
Drugs |
Planning Bioequivalence Studies of Drugs with Narrow Therapeutic Indices |
|
| Vol 50, No 12 (2017) |
Article |
Certification of Human Immunoglobulin Standard Samples for Determination of Anticomplementary Activity |
|
| Vol 51, No 4 (2017) |
Drug Synthesis Methods and Manufacturing Technology |
Lyophilization as a Method for Stabilizing Pharmaceuticals |
|
| Vol 51, No 5 (2017) |
Drugs |
Influence of Human Biorhythms on the Blood Glucose Level and the Efficacy of Hypoglycemic Drugs (Review) |
|
| Vol 51, No 6 (2017) |
Article |
Toxic and Immunomodulatory Properties of an Iron(II) Coordination Complex of Isoleucyltryptophan Dipeptide |
|
| Vol 51, No 8 (2017) |
Article |
Optimization of Drug Administration Dosage Regimen Considering Chronorhythms and Desynchronosis of Gastrointestinal-Tract Organs |
|
| Vol 51, No 11 (2018) |
Drugs |
Interchangeability Issues with Glaucoma Medicines Using Latanoprost as an Example |
|
| Vol 51, No 11 (2018) |
Article |
Validation of a Quantitative Determination Method for Ormustine in a Lyophilized Dosage Form |
|
| Vol 52, No 7 (2018) |
Article |
Synthesis and some Pharmacological Properties of an Immunoactive Lysine-Containing Tetrapeptide |
|
| Vol 52, No 9 (2018) |
Article |
Validation of an Assay Procedure for Ormustine in a Liposomal Dosage Form |
|
